Gerresheimer Ag · XETR:GXI
Gerresheimer — Q3 2025 Earnings Presentation
12 slides from Gerresheimer's earnings presentation, Oct 9, 2025
Slide 1: Q3/9M 2025 Preliminary Results
Q3/9M 2025 Preliminary Results Dietmar Siemssen Wolf Lehmann
Slide 2: Disclaimer
Disclaimer This presentation may contain certain forward-looking statements, including assumptions, opinions and views of the Company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or
Slide 3: Preliminary Q3 and 9M 2025 Overview
Preliminary Q3 and 9M 2025 Overview Dietmar Siemssen (CEO)
Slide 4: Preliminary 9M/Q3 2025 – Lower than Expected Growth and Profitability
Preliminary 9M/Q3 2025 – Lower than Expected Growth and Profitability 2025 Guidance adjusted despite stronger Q4 3Q 2025 Results 9 Months YTD (9M) 2025 Results Revenues (EURm) Adjusted EBITDA (EURm) Revenues (EURm) Adjusted EBITDA (EURm) Organic growth yoy1 -1.2% Organic growth yoy1 -9.4% Organic gr
Slide 5: Financial Performance Preliminary Q3 and 9M 2025
Financial Performance Preliminary Q3 and 9M 2025 Wolf Lehmann (CFO)
Slide 6: Preliminary Q3 2025 Development
Preliminary Q3 2025 Development Cosmetics and Oral Liquids Market Softness - Lower Demand for Bulk Vials 2024 figures on pro-forma basis Revenues (EURm) Adj. EBITDA (EURm) Adj. EPS (EURm) Organic growth yoy1 -1.2% Organic growth yoy1 -9.4% Organic growth yoy1 -35.8% • Moulded Glass (EUR -13m): Cosme
Slide 7: Preliminary 9M 2025 Development
Preliminary 9M 2025 Development Cosmetics and Oral Liquids Market Softness - Lower Demand for Bulk Vials 2024 figures on pro-forma basis Revenues (EURm) Adj. EBITDA (EURm) Adj. EPS (EURm) Organic growth yoy1 -1.8% Organic growth yoy1 -7.5% Organic growth yoy1 -32.5% 341 • Lower Oral Liquids revenues
Slide 8: Softer Q3/9M Necessitates Guidance Adjustment Despite Expected QoQ growth in Q4
Softer Q3/9M Necessitates Guidance Adjustment Despite Expected QoQ growth in Q4 Adjusted FY 2025 Guidance (organic; group level) Revenue Adjusted EBITDA Adj. EPS1 Old New Old New Old New FY 2025 -4% to -2% 18.5%-19% MDD% Growth Margin 2 Decline2 • Lower Business Performance in Q3 2025, in the Cosmet
Slide 9: People – Changes in the Leadership Team to Accelerate Transformation
People – Changes in the Leadership Team to Accelerate Transformation Wolf Lehmann Achim Schalk Hans-Norbert Topp Chief Financial Member of the Executive Vice President Officer Executive Board Moulded Glass September 2025 November 2025 August 2025 • Progressing on Moulded Glass (MG) separation; hired
Slide 10: Summary
Summary Dietmar Siemssen (CEO)
Slide 11: Executive Summary
Executive Summary Preliminary Q3 Results & Adjusted Guidance Results: continued market softness; Q3 and 9M with lower revenues and adj. EBITDA YoY; Q3 with EUR 21m positive free cash flow Guidance: FY 2025 organic revenue growth revised to -4% to -2% (prior: 0-2%); Adjusted EBITDA margin revised to
Slide 12: innovating for a better life
innovating for a better life